SCHEMBL6606038

SCHEMBL6606038

CCCCOC(=O)CCN1CCNCC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH2 P25021 4/20 0.54
▸ HRH1 P35367 4/20 0.54
▸ THRB P10828 7/20 0.44
▸ ALDH1A1 P00352 6/20 0.44
▸ LMNA P02545 3/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CHRM2 P08172 1/20 0.44
▸ CHRM4 P08173 1/20 0.44
▸ CHRM5 P08912 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ ADRA2C P18825 1/20 0.44
▸ DRD4 P21917 1/20 0.44
▸ ACHE P22303 1/20 0.44
▸ SLC6A2 P23975 1/20 0.44
▸ HTR2A P28223 1/20 0.44
▸ ADRA1A P35348 1/20 0.44
▸ SLC6A3 Q01959 1/20 0.44
▸ PDE4D Q08499 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL31722504 0.98 HRH2 (0.53) HRH2HRH1THRBALDH1A1LMNA
SCHEMBL30066615 0.92 HRH2 (0.56) HRH2HRH1THRBALDH1A1LMNA
SCHEMBL26063859 0.91 HRH2 (0.58) HRH2HRH1ALDH1A1MAPK1DGKA
SCHEMBL26364351 0.90 HRH2 (0.57) HRH2HRH1ALDH1A1DGKAMAPT
SCHEMBL16062671 0.90 HRH2 (0.45) HRH2HRH1THRBLMNADGKA
SCHEMBL22743444 0.89 HRH2 (0.42) HRH2HRH1THRBALDH1A1HRH3
SCHEMBL673095 0.89 DGKA (0.50) HRH2HRH1THRBALDH1A1LMNA
SCHEMBL11598618 0.89 DGKA (0.50) HRH2HRH1THRBALDH1A1LMNA
SCHEMBL29001314 0.87 HRH2 (0.54) HRH2HRH1THRBLMNADGKA
SCHEMBL11779963 0.87 HRH2 (0.60) HRH2HRH1ALDH1A1DGKAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114394898-A Preparation method of 5-oxohexanoate 山东智永化工产业技术研究院有限公司 2022-04-26 — — CN claimed
WO-2025228947-A1 BIFUNCTIONAL COMPOUNDS CAPABLE OF INDUCING DEGRADATION OF POLO-LIKE KINASE1 CROSSFIRE ONCOLOGY B.V. (NL) 2025-11-06 — — WO disclosed
EP-4634184-A1 BIFUNCTIONAL COMPOUNDS FOR DEGRADING KINASES VIA UBIQUITIN PROTEOSOME PATHWAY Crossfire Oncology Holding B.V. (NL) 2025-10-22 — — EP disclosed
WO-2024126617-A1 BIFUNCTIONAL COMPOUNDS FOR DEGRADING KINASES VIA UBIQUITIN PROTEOSOME PATHWAY CROSSFIRE ONCOLOGY HOLDING B.V. (NL) 2024-06-20 — — WO disclosed
CN-114394898-A Preparation method of 5-oxohexanoate 山东智永化工产业技术研究院有限公司 2022-04-26 — — CN disclosed
EP-0741133-B1 Adhesion receptor antagonists MERCK PATENT GMBH (DE) 2004-01-28 — — EP disclosed
US-6455529-B1 OXAZOLIDIN-2-ONE DERIVATIVES; ANTICOAGULANTS; ANTIMETASTASIS, ANTICARCINOGENIC, ANTIISCHEMIC, AND ANTIINFLAMMATORY AGENTS; OSTEOPOROSIS, ARTERIOSCLEROSIS MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2002-09-24 — — US disclosed
EP-0741133-A2 Adhesion receptor antagonists MERCK PATENT GmbH (DE) 1996-11-06 — — EP disclosed
EP-0399986-A1 Zwitterionic tertiary ammonium dithiocarbamates MONSANTO COMPANY (US) 1990-11-28 — — EP disclosed
Send feedback